keyword
https://read.qxmd.com/read/38629803/60-years-of-the-3rs-symposium-lessons-learned-and-the-road-ahead
#1
JOURNAL ARTICLE
Michael Balls, Rolf Bass, Rodger Curren, Julia Fentem, Alan Goldberg, Thomas Hartung, Kathrin Herrmann, Nicole C Kleinstreuer, Lisa Libowitz, John Parascandola, Andrew Rowan, Horst Spielmann, Martin L Stephens, Russell S Thomas, Katya Tsaioun
When The Principles of Humane Experimental Technique was published in 1959, authors William Russell and Rex Burch had a modest goal: to make researchers think about what they were doing in the laboratory - and to do it more humanely. Sixty years later, their groundbreaking book was celebrated for inspiring a revolution in science and launching a new field: The 3Rs of alternatives to animal experimentation. On November 22, 2019, some pioneering and leading scientists and researchers in the field gathered at the Johns Hopkins Bloomberg School of Public Health in Bal-timore for the 60 Years of the 3Rs Symposium: Lessons Learned and the Road Ahead...
2024: ALTEX
https://read.qxmd.com/read/38606256/posterior-reversible-encephalopathy-syndrome-in-a-late-postpartum-patient-with-a-rare-complication-of-subarachnoid-hemorrhage
#2
Zara H Siddiqui, Justin G Hovey, James S Bolton
Posterior reversible encephalopathy syndrome (PRES) is considered a neuroclinical syndrome of headache, confusion, visual changes, and seizures associated with neuroimaging findings of posterior cerebral white matter edema. Although the incidence of the syndrome is largely unknown, this condition is becoming increasingly recognized. The prognosis is generally good with most symptoms resolving within one week and lesions on imaging resolving in two weeks. Death and significant neurological disability have been reported but are relatively rare...
March 2024: Curēus
https://read.qxmd.com/read/38604255/defining-remission-in-childhood-onset-lupus-pres-endorsed-consensus-definitions-by-an-international-task-force
#3
JOURNAL ARTICLE
E M D Smith, A Aggarwal, J Ainsworth, E Al-Abadi, T Avcin, L Bortey, J Burnham, C Ciurtin, C M Hedrich, S Kamphuis, L Lambert, D M Levy, L Lewandowski, N Maxwell, E Morand, S Özen, C E Pain, A Ravelli, C Saad Magalhaes, C Pilkington, D Schonenberg-Meinema, C Scott, K Tullus, M W Beresford, B Goilav, N Goss, L Oni, S D Marks
OBJECTIVE: To derive childhood-onset SLE (cSLE) specific remission definitions for future treat-to-target (T2T) trials, observational studies, and clinical practice. METHODS: The cSLE International T2T Task Force conducted Delphi surveys exploring paediatric perspectives on adult-onset SLE remission targets. A modified nominal group technique was used to discuss, refine, and agree on the cSLE remission target criteria. RESULTS: The Task Force proposed two definitions of remission: 'cSLE clinical remission on steroids (cCR)' and 'cSLE clinical remission off steroids (cCR-0)'...
April 9, 2024: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/38595578/a-rare-case-of-postpartum-paraplegia-a-case-report
#4
Dinesh Kumar, Gursimran Kaur, Suhaavi Kaur Chawla, Harroop Singh
In this case report, a 27-year-old woman who had pre-eclampsia in the past and had a cesarean section as a result of the condition presents with an uncommon and difficult form of postpartum paraplegia. She experienced bilateral lower limb paralysis and urine incontinence soon after the surgery, which quickly led to unconsciousness and required mechanical ventilator support and intensive care treatment. Comprehensive diagnostic testing, which included magnetic resonance imaging scans of the brain and spinal cord, identified signs typical of " Posterior Reversible Encephalopathy Syndrome (PRES)" and spinal cord infarction affecting segments C3 to D2...
February 2024: Journal of Pharmacy & Bioallied Sciences
https://read.qxmd.com/read/38579434/pediatric-reversible-cerebral-vasoconstriction-syndrome-posterior-encephalopathy-syndrome-poststreptococcal-glomerulonephritis
#5
JOURNAL ARTICLE
Yuki Kawashima, Shohei Ariji, Rui Aoyagi, Masahiro Noda, Kunihiro Oba, Masashi Ogasawara
No abstract text is available yet for this article.
March 16, 2024: Pediatric Neurology
https://read.qxmd.com/read/38576656/posterior-reversible-encephalopathy-syndrome-with-hemorrhagic-transformation-in-the-postoperative-period-of-a-kidney-transplant
#6
Edgar Dehesa-Lopez, Sergio Saul Irizar-Santana, Miguel Angel Valdez-Cruz, Sarahy Sosa-Guerrero, Fatima Lopez-Moreno
Patients with end-stage renal disease (ESRD) who undergo kidney transplantation are at an increased risk of developing surgical and/or medical complications. Posterior reversible encephalopathy syndrome (PRES) is a rare complication that occurs in 0.34% of kidney transplant patients. It is characterized by a combination of neurological manifestations, risk factors, and characteristic radiological findings in neuroimaging studies. The development of PRES has been associated with various medical conditions and factors, including hypertension, the use of cytotoxic and immunosuppressive drugs, acute or chronic kidney disease, pre-eclampsia/eclampsia, autoimmune diseases, and solid organ and bone marrow transplantation...
March 2024: Curēus
https://read.qxmd.com/read/38571843/preeclampsia-with-posterior-reversible-encephalopathy-syndrome-at-19-weeks-gestation-resulting-in-intrauterine-fetal-demise
#7
Zara H Siddiqui, Kyle A Cohen, Jonathan Scott
Posterior reversible encephalopathy syndrome (PRES) can be defined as a clinical syndrome of headache, seizures, visual disturbance, altered mental status, and characteristic magnetic resonance imaging (MRI) findings of vasogenic edema in the posterior subcortical parietal-occipital white matter. There are numerous potential inciting factors, including immunosuppression, renal disease, malignancy, cytotoxic medications, hypertension, preeclampsia, and eclampsia. In this paper, we present the case of a 21-year-old female at 19 weeks gestation presenting with symptoms consistent with preeclampsia with severe features and PRES...
March 2024: Curēus
https://read.qxmd.com/read/38550455/isolated-infratentorial-posterior-reversible-encephalopathy-syndrome-pres-in-nephrotic-syndrome-a-case-report
#8
Umair Hamid, Faryal A Umair, Deepak Nair
We present a case of infratentorial variant posterior reversible encephalopathy syndrome (PRES), which is a very rare presentation of PRES. Atypical PRES is more common than the typical parieto-occipital PRES. We present a 43-year-old male who presented with acute change in mentation, left gaze deviation, and paraparesis with initial blood pressures of 230/120 with anasarca. In the present admission, his CT showed diffuse infratentorial hypodensity. Computed tomography angiography (CTA) was negative for large vessel occlusion...
February 2024: Curēus
https://read.qxmd.com/read/38543863/vaccine-based-on-recombinant-fusion-protein-combining-hepatitis-b-virus-pres-with-sars-cov-2-wild-type-and-omicron-derived-receptor-binding-domain-strongly-induces-omicron-neutralizing-antibodies-in-a-murine-model
#9
JOURNAL ARTICLE
Pia Gattinger, Bernhard Kratzer, Al Nasar Ahmed Sehgal, Anna Ohradanova-Repic, Laura Gebetsberger, Gabor Tajti, Margarete Focke-Tejkl, Mirjam Schaar, Verena Fuhrmann, Lukas Petrowitsch, Walter Keller, Sandra Högler, Hannes Stockinger, Winfried F Pickl, Rudolf Valenta
BACKGROUND: COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a recurrent endemic disease affecting the whole world. Since November 2021, Omicron and its subvariants have dominated in the spread of the disease. In order to prevent severe courses of disease, vaccines are needed to boost and maintain antibody levels capable of neutralizing Omicron. Recently, we produced and characterized a SARS-CoV-2 vaccine based on a recombinant fusion protein consisting of hepatitis B virus (HBV)-derived PreS and two SARS-CoV-2 wild-type RBDs...
February 23, 2024: Vaccines
https://read.qxmd.com/read/38527423/posterior-reversible-encephalopathy-syndrome-in-eclamptic-patients-the-relationship-between-blood-pressure-cranial-involvement-and-seizure-recurrence
#10
JOURNAL ARTICLE
Musa Temel, Merve Durmuş, Şeyma Eroğlu Durmaz, Deniz Güvenir, Erdem Gürkaş
OBJECTIVES: Posterior reversible encephalopathy syndrome(PRES) is a clinic radiological disorder characterized by headache, epileptic seizure, encephalopathy, visual impairment, and focal neurological deficits. Gestational hypertension, which is a significant risk factor for PRES, may cause significant morbidity and mortality among pregnant women. DESIGN: Twenty-four patients with PRES caused by eclampsia who were admitted to our hospital in the last 5 years were included in this study...
March 25, 2024: Gynecologic and Obstetric Investigation
https://read.qxmd.com/read/38524039/cocaine-induced-toxic-leukoencephalopathy-a-case-report
#11
Shayet Hossain Eshan, Andranik Bedross, Gopika Chandra, Jose R Medina Inojosa, Shyam Chalise
We present a case here where a 57-year-old South Asian male with disturbed mental status developed multifocal leukoencephalopathy, which we believe was caused by cocaine usage. Cocaine was detected in the urine toxicological sample. Non-acute CT head, with a follow-up brain MRI demonstrating hyperintensity of the T2 FLAIR signal corresponding to diffusion restriction throughout the whole supratentorial white matter, involving semiovale and subcortical U fibres in the occipital lobes as well as posterior frontal and parietal centrum...
February 2024: Curēus
https://read.qxmd.com/read/38515774/paclitaxel-combined-with-trastuzumab-chemotherapy-related-posterior-reversible-encephalopathy-syndrome-a-case-report-and-literature-review
#12
Jing Li, Yanlan Huang, Qifang Lao
Posterior reversible encephalopathy syndrome (PRES) in breast carcinoma is a rare disease in clinical practice that is often misdiagnosed and ignored. This study reported a case of a patient admitted to our hospital and discussed the clinical, imaging, and pathogenesis properties of the disease. We retrospectively analyzed the clinical data of this patient and reviewed the relevant literature. Imaging was used to diagnose PRES based on clinical findings, and clinical symptoms improved after discontinuation of the relevant drugs...
June 2024: Radiology Case Reports
https://read.qxmd.com/read/38485406/-not-available
#13
JOURNAL ARTICLE
Faustine Thevenon, Valentina Zambelli
No abstract text is available yet for this article.
March 2024: Revue de L'infirmière
https://read.qxmd.com/read/38480646/association-between-renal-insufficiency-and-lesion-characteristics-of-posterior-reversible-encephalopathy-syndrome
#14
JOURNAL ARTICLE
Dong Young Jeong, Yea Na Shin, Sang Hee Ha, Jun Young Chang, Dong-Wha Kang, Sun U Kwon, Bum Joon Kim
BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) is characterized by cerebral blood flow dysregulation and the blood-brain barrier (BBB) disruption. While renal insufficiency has been considered a factor in BBB fragility, the relationship between renal insufficiency and the PRES lesions volume remains unclear. METHODS: This observational study was performed retrospectively. PRES patients were categorized into two groups with renal insufficiency, defined as an estimated glomerular filtration rate (eGFR) of less than 60 mL/min/1...
March 14, 2024: Neurological Sciences
https://read.qxmd.com/read/38478961/analysis-of-drug-induced-posterior-reversible-encephalopathy-syndrome-using-the-food-and-drug-administration-adverse-drug-events-reporting-system-database
#15
JOURNAL ARTICLE
Cai-Lu Lei, Xiao-Long Gui, Lin-Yu Wang, You-Jia Guo, Yan Li
OBJECTIVE: In this retrospective pharmacovigilance study, we gathered data on drug-induced posterior reversible encephalopathy syndrome (PRES). Our goal was to identify the primary suspect drugs in PRES by analyzing the Food and Drug Administration Adverse Events Reporting System (FAERS) database. METHODS: We identified and analyzed reports of PRES listed in the FAERS database between 2004 and 2021. Using the reporting odds ratio and 95% confidence interval, we evaluated the safety signals for each of the drugs associated with PRES...
March 13, 2024: Expert Opinion on Drug Safety
https://read.qxmd.com/read/38470001/frequency-of-ischaemic-stroke-and-intracranial-haemorrhage-in-patients-with-reversible-cerebral-vasoconstriction-syndrome-rcvs-and-posterior-reversible-encephalopathy-syndrome-pres-a-systematic-review
#16
JOURNAL ARTICLE
Jana Kaufmann, Philipp Buecke, Thomas Meinel, Morin Beyeler, Adrian Scutelnic, Johannes Kaesmacher, Adnan Mujanović, Thomas Dobrocky, Hakim Arsany, Nils Peters, Werner Z'Graggen, Simon Jung, David Seiffge
BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) may cause ischaemic stroke and intracranial haemorrhage. The aim of our study was to assess the frequency of the afore-mentioned outcomes. METHODS: We performed a PROSPERO-registered (CRD42022355704) systematic review and meta-analysis accessing PubMed until 7 November 2022. The inclusion criteria were: (1) original publication, (2) adult patients (≥18 years), (3) enrolling patients with PRES and/or RCVS, (4) English language and (5) outcome information...
March 12, 2024: European Journal of Neurology
https://read.qxmd.com/read/38463101/reversible-cerebral-vasoconstriction-syndrome-and-posterior-reversible-encephalopathy-syndrome-following-vaccination-analysis-of-the-vaers-database-and-systematic-review
#17
JOURNAL ARTICLE
Bahadar S Srichawla, Ton Fang, Vincent Kipkorir, Maria A Garcia-Dominguez
OBJECTIVES: This study aimed to analyze the Vaccine Adverse Event Reporting System (VAERS) database and systematically review the literature to provide a comprehensive analysis of reversible cerebral vasoconstriction syndrome (RCVS) and posterior reversible encephalopathy syndrome (PRES) secondary to vaccination. METHODS: The authors analyzed the VAERS database and conducted a systematic review following PRISMA guidelines. The inclusion criteria for VAERS data were a score of ≥3 on the RCVS2 score and/or radiographic findings consistent with the diagnosis of RCVS or PRES...
March 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38460049/tacrolimus-associated-neurotoxicity-isolated-to-the-brainstem-two-illustrative-cases-and-a-systematic-review-of-the-literature
#18
REVIEW
Simone Rossi, Rita Rinaldi, Gian Maria Asioli, Valentina Barone, Paolo Pianta, Matteo Cescon, Maria Cristina Morelli, Luca Faccioli, Luca Spinardi, Pietro Cortelli, Maria Guarino
INTRODUCTION: Tacrolimus-associated neurotoxicity (TAN) manifests with wide clinical spectrum, ranging from mild tremors to severe encephalopathy. The isolated involvement of the brainstem is a rarely documented presentation of TAN, and its clinical and diagnostic characteristics are unclear. METHODS: We report two cases of brainstem-isolated TAN (bi-TAN). Moreover, we performed a systematic review of the literature on bi-TAN and extracted data concerning demographics, clinical characteristics, radiological features, and management...
March 9, 2024: Neurological Sciences
https://read.qxmd.com/read/38446988/comparison-of-clinical-and-laboratory-data-of-adult-patients-with-cutaneous-iga-vasculitis-and-non-iga-vasculitis
#19
JOURNAL ARTICLE
Thilo Gambichler, Duyên Bui, Belanna Domin, Larisa Ardabili, Yusa Devrim, Nessr Abu Rached, Laura Susok
BACKGROUND: Immune complex vasculitides may be subdivided into adult IgA small vessel vasculitis (aIgA-SVV, adult Henoch-Schönlein purpura) and non-IgA-SVV (hypersensitivity vasculitis, etc.). OBJECTIVES: We aimed to evaluate clinical and laboratory parameters of inpatients fulfilling the diagnostic criteria for aIgA-SVV and non-IgA-SVV. METHODS: 29 adult patients (≥ 20years) with aIgA-SVV according to the EULAR/PRINTO/PRES criteria and 53 adult patients with non-IgA-SVV according to the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides were compared with respect to a variety of clinical and laboratory parameters using uni- and multivariable statistics...
March 6, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38444915/posterior-reversible-encephalopathy-syndrome-associated-with-dengue-fever-induced-intrauterine-death-a-case-report
#20
Himel Kumar Biswas, Khadija Tanbil Ishaque Ibu, Rama Biswas, Md Nasir Uddin Ahmed
In recent years dengue fever has become a major health concern specifically due to its diverse presentation and adverse outcome. Progression from mild febrile illness to a severe systemic illness may occur in dengue fever including neurological disorder. Here, we report an unusual and rare case of a 20-year-old mother who developed posterior reversible encephalopathy syndrome (PRES) following dengue fever induced intrauterine death and septic shock.
March 2024: Clinical Case Reports
keyword
keyword
1526
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.